4563. Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review.
Despite recent studies that failed to show catastrophic effects of prenatal cocaine exposure, popular attitudes and public policies still reflect the belief that cocaine is a uniquely dangerous teratogen.
4564. Reproductive period and risk of dementia in postmenopausal women.
作者: M I Geerlings.;A Ruitenberg.;J C Witteman.;J C van Swieten.;A Hofman.;C M van Duijn.;M M Breteler.;L J Launer.
来源: JAMA. 2001年285卷11期1475-81页
Exogenous estrogen use may lower risk of dementia in postmenopausal women. A relationship between long-term exposure to endogenous estrogens and incident dementia has been hypothesized but not studied.
4565. Mapping of a gene for severe pediatric gastroesophageal reflux to chromosome 13q14.
作者: F Z Hu.;R A Preston.;J C Post.;G J White.;L W Kikuchi.;X Wang.;S M Leal.;M A Levenstien.;J Ott.;T W Self.;G Allen.;R S Stiffler.;C McGraw.;E A Pulsifer-Anderson.;G D Ehrlich.
来源: JAMA. 2000年284卷3期325-34页
Gastroesophageal reflux (GER) has not previously been widely regarded as a hereditary disease. A few reports have suggested, however, that a genetic component may contribute to the incidence of GER, especially in its severe or chronic forms.
4566. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
作者: R A Mulnard.;C W Cotman.;C Kawas.;C H van Dyck.;M Sano.;R Doody.;E Koss.;E Pfeiffer.;S Jin.;A Gamst.;M Grundman.;R Thomas.;L J Thal.
来源: JAMA. 2000年283卷8期1007-15页
Several reports from small clinical trials have suggested that estrogen replacement therapy may be useful for the treatment of Alzheimer disease (AD) in women.
4567. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels.
作者: S Bhasin.;T W Storer.;M Javanbakht.;N Berman.;K E Yarasheski.;J Phillips.;M Dike.;I Sinha-Hikim.;R Shen.;R D Hays.;G Beall.
来源: JAMA. 2000年283卷6期763-70页
Previous studies of testosterone supplementation in HIV-infected men failed to demonstrate improvement in muscle strength. The effects of resistance exercise combined with testosterone supplementation in HIV-infected men are unknown.
4569. Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant.
Few studies document how parents adapt to the experience of a very low-birth-weight (VLBW; <1500 g) birth despite societal concerns about the ethics and justification of intensive care for these infants.
4570. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.
作者: S R Cummings.;D M Black.;D E Thompson.;W B Applegate.;E Barrett-Connor.;T A Musliner.;L Palermo.;R Prineas.;S M Rubin.;J C Scott.;T Vogt.;R Wallace.;A J Yates.;A Z LaCroix.
来源: JAMA. 1998年280卷24期2077-82页
Alendronate sodium reduces fracture risk in postmenopausal women who have vertebral fractures, but its effects on fracture risk have not been studied for women without vertebral fractures.
4571. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial.
作者: J Q Purnell.;J E Hokanson.;S M Marcovina.;M W Steffes.;P A Cleary.;J D Brunzell.
来源: JAMA. 1998年280卷2期140-6页
Intensive treatment of type 1 diabetes results in greater weight gain than conventional treatment.
4572. Consolidation of medical groups into physician practice management organizations.
Medical groups are growing and merging to improve efficiency and bargaining leverage in the competitive managed care environment. An increasing number are affiliating with physician practice management (PPM) firms that offer capital financing, expertise in utilization management, and global capitation contracts with health insurance entities. These physician organizations provide an alternative to affiliation with a hospital system and to individual physician contracting with health plans.
4573. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.
作者: I M Graham.;L E Daly.;H M Refsum.;K Robinson.;L E Brattström.;P M Ueland.;R J Palma-Reis.;G H Boers.;R G Sheahan.;B Israelsson.;C S Uiterwaal.;R Meleady.;D McMaster.;P Verhoef.;J Witteman.;P Rubba.;H Bellet.;J C Wautrecht.;H W de Valk.;A C Sales Lúis.;F M Parrot-Rouland.;K S Tan.;I Higgins.;D Garcon.;G Andria.
来源: JAMA. 1997年277卷22期1775-81页
Elevated plasma homocysteine is a known risk factor for atherosclerotic vascular disease, but the strength of the relationship and the interaction of plasma homocysteine with other risk factors are unclear.
4574. Variations in cataract extraction rates in Medicare prepaid and fee-for-service settings.
作者: C L Goldzweig.;B S Mittman.;G M Carter.;T Donyo.;R H Brook.;P Lee.;C M Mangione.
来源: JAMA. 1997年277卷22期1765-8页
To compare rates of cataract extraction in 2 prepaid health settings and in traditional fee-for-service (FFS) settings.
4575. Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study.
作者: J F Timsit.;V Sebille.;J C Farkas.;B Misset.;J B Martin.;S Chevret.;J Carlet.
来源: JAMA. 1996年276卷17期1416-20页
To evaluate the effect of catheter tunneling on internal jugular catheter-related sepsis in critically ill patients.
4577. The risk of myocardial infarction associated with antihypertensive drug therapies.
作者: B M Psaty.;S R Heckbert.;T D Koepsell.;D S Siscovick.;T E Raghunathan.;N S Weiss.;F R Rosendaal.;R N Lemaitre.;N L Smith.;P W Wahl.
来源: JAMA. 1995年274卷8期620-5页
To assess the association between first myocardial infarction and the use of antihypertensive agents.
4578. Periodic treatment regimens with inhaled steroids in asthma or chronic obstructive pulmonary disease. Is it possible?
作者: C P van Schayck.;P J van den Broek.;J J den Otter.;C L van Herwaarden.;J Molema.;C van Weel.
来源: JAMA. 1995年274卷2期161-4页
To determine whether inhaled corticosteroids can be discontinued in the stable phase of asthma or chronic obstructive pulmonary disease (COPD) or if this therapy should be continued.
|